Central Diabetes Insipidus Following Immunization With BNT162b2 mRNA COVID-19 Vaccine: A Case Report.

Bouça, Bruno; Roldão, Marisa; Bogalho, Paula; Cerqueira, Luís; Silva-Nunes, José

Bouça, Bruno; Roldão, Marisa; Bogalho, Paula; Cerqueira, Luís; Silva-Nunes, José.

Afiliación

Bouça B; Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Roldão M; Department of Nephrology, Centro Hospitalar do Médio Tejo, Torres Novas, Portugal.
Bogalho P; Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Cerqueira L; Department of Neuroradiology, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Silva-Nunes J; Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.

Front Endocrinol (Lausanne) ; 13: 889074, 2022.

Article en En | MEDLINE | ID: mdl-35600593

Asunto(s)

COVID-19; Diabetes Insípida Neurogénica; Diabetes Mellitus; Hipofisitis; Adulto; Vacuna BNT162; COVID-19/prevención & control; Vacunas contra la COVID-19/efectos adversos; Diabetes Insípida Neurogénica/complicaciones; Diabetes Insípida Neurogénica/etiología; Femenino; Humanos; Hipofisitis/complicaciones; Inmunización/efectos adversos; ARN Mensajero

Palabras clave

COVID-19; case report; diabetes insipidus; mRNA; vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Insípida Neurogénica / Diabetes Mellitus / Hipofisitis / COVID-19 Tipo de estudio: Etiology_studies Límite: Adult / Female / Humans Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: Portugal

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google